Bosentan
CAS 147536-97-8
Overview
Bosentan is a dual endothelin receptor antagonist medication used in the treatment of pulmonary artery hypertension. Bosentan is available as film-coated tablets or as dispersable tablets for oral suspension
Anant Labs manufacture and furnish high quality Bosentan impurities for global markets. Our Bosentan EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Technical Data
CAS147536-97-8
Mol. FormulaC27H29N5O6S
Mol. Weight551.625 g/mol
IUPAC4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide
SMILESCC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
InChIInChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)
InChI KeyGJPICJJJRGTNOD-UHFFFAOYSA-N
Note: We are upgrading our system, Cat No will change.
Synonyms
Bosentan147536-97-8Tracleerbosentan anhydrousRo 47-0203bosentanumRo-47-0203Anhydrous bosentanDTXSID7046627p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide
